D-1325-2015 Class II Terminated
FDA drug recall D-1325-2015 was initiated by Dr. Reddy's Laboratories, Inc. on Aug 3, 2015 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Mar 24, 2017). Affected quantity: 2,952 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 19, 2015
- Initiation Date
- Aug 3, 2015
- Termination Date
- Mar 24, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,952 bottles
Product description
Rivastigmine Tartrate Capsules, USP 1.5 mg, 60 count bottle, Rx Only, Mfd. By Dr. Reddy's Laboratories Limited, Bachupally, India, NDC 55111-352-60
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide
Code information
Lot #: C501342; Exp 01/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1325-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026